EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Immunomodulatory Phytochemicals in Cancer: Mechanistic Pathways and Translational Potential

Payal Bajaj, Ajay Kumar iD, Brahmjot Singh, Varinder Kaur, Amita, Bunty Sharma, Purnima Jindal, Shafiul Haque, Hardeep Singh Tuli

Chemistry & Biodiversity · 2026-02 · 23 (2)

DOI: 10.1002/cbdv.202502737 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, online erschienen am 25.02.2026. Verfasst von Payal Bajaj und 8 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Eye Center, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. Die Arbeit nennt 237 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer development is linked to dysregulated immune surveillance, chronic inflammation, and immunosuppressive signaling within the tumor microenvironment. Emerging evidence suggests that the anticancer effects of naturally occurring phytochemicals are not directly mediated by cytotoxicity but rather by altering key components of both innate and adaptive immunity. Over the last few years, significant progress has been made in understanding the interactions of specific classes of phytochemicals, including polyphenols, flavonoids, alkaloids, and terpenoids, with immune‐linked signal transduction mechanisms involved in carcinogenesis. These include the suppression of pro‐ and anti‐inflammatory mediators, the control of immune checkpoint‐related pathways, the polarization of tumor‐associated macrophages, the enhancement of cytotoxic T‐cell and natural killer cell functions, and the suppression of angiogenic and metastatic signaling. Notably, many phytochemicals have demonstrated translational relevance, and some have advanced to later clinical trial phases. This narrative review highlights the recent preclinical, translational, and clinical evidence on the immunomodulatory effects of phytochemicals in cancer prevention and treatment. There is an accentuated focus on mechanistic convergence, the strength of the evidence, and translational potential, and the most frequently targeted immune pathways by phytochemicals are identified, with a highlight of the major challenges of integrating them into contemporary anticancer approaches.

Schlagwörter

Stichwörter der Autor:innen

cancer chemopreventioncancer immunomodulationimmune signaling pathwaysphytochemicalstumor microenvironment

Autor:innen und Institutionen

  • Advanced Eye Center, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • University Center for Research & Development (UCRD), Chandigarh University, Mohali, India.
  • Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, India.
  • Cancer Centre, Townsville University Hospital (TUH), Douglas, Australia.
  • Department of Physiotherapy, Guru Jambheshwar University of Science & Technology, Hisar, India.
  • Department of Biotechnology, Graphic Era (Deemed to Be University), Dehradun, India.

ORCID-Profile: Ajay Kumar

Zitieren

APA

Bajaj, P., Kumar, A., Singh, B., Kaur, V., Amita, Sharma, B., Jindal, P., Haque, S., & Tuli, H. S. (2026). Immunomodulatory Phytochemicals in Cancer: Mechanistic Pathways and Translational Potential. Chemistry & Biodiversity, 23(2). https://doi.org/10.1002/cbdv.202502737

Vancouver

Bajaj P, Kumar A, Singh B, Kaur V, Amita, Sharma B, et al. Immunomodulatory Phytochemicals in Cancer: Mechanistic Pathways and Translational Potential. Chemistry & Biodiversity. 2026;23(2). doi:10.1002/cbdv.202502737

BibTeX
@article{Bajaj2026,
  author = {Bajaj, Payal and Kumar, Ajay and Singh, Brahmjot and Kaur, Varinder and Amita, Amita and Sharma, Bunty and Jindal, Purnima and Haque, Shafiul and Tuli, Hardeep Singh},
  title = {Immunomodulatory Phytochemicals in Cancer: Mechanistic Pathways and Translational Potential},
  journal = {Chemistry & Biodiversity},
  year = {2026},
  volume = {23},
  number = {2},
  doi = {10.1002/cbdv.202502737}
}
Kostenlos starten →